VICARIOUS SURGICAL INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value
VICARIOUS SURGICAL INC. (RBOT) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value of $4.92 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-09.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 · last filed 2026-03-09
- VICARIOUS SURGICAL INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for the quarter ending 2025-12-31 was $124.00K, a 90.77% increase year-over-year.
- VICARIOUS SURGICAL INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for the quarter ending 2025-09-30 was $2.22M, a 2482.56% increase year-over-year.
- VICARIOUS SURGICAL INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for the quarter ending 2025-06-30 was $2.55M, a 48.69% increase year-over-year.
- VICARIOUS SURGICAL INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for the quarter ending 2025-03-31 was $27.00K, a 92.70% decline year-over-year.
- VICARIOUS SURGICAL INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2025 was $4.92M, a 120.13% increase from fiscal 2024.
- VICARIOUS SURGICAL INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2024 was $2.24M, a 60.43% decline from fiscal 2023.
- VICARIOUS SURGICAL INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2023 was $5.65M, a 63.45% decline from fiscal 2022.
- VICARIOUS SURGICAL INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2022 was $15.46M, a 27.31% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 3 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 9 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2025-12-31 | $124.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $2.35M derived: sum of 2 quarters · filed 2026-03-09 | $4.89M derived: sum of 3 quarters · filed 2026-03-09 | $4.92M 10-K · filed 2026-03-09 | |||
| 2025-09-30 | $2.22M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $4.77M derived: sum of 2 quarters · filed 2025-11-12 | $4.80M 10-Q · filed 2025-11-12 | $4.86M derived: sum of 4 quarters · filed 2026-03-09 | |||
| 2025-06-30 | $2.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $2.58M 10-Q · filed 2025-08-12 | $2.64M derived: sum of 3 quarters · filed 2026-03-09 | $2.73M derived: sum of 4 quarters · filed 2026-03-09 | |||
| 2025-03-31 | $27.00K 10-Q · filed 2025-05-12 | $92.00K derived: sum of 2 quarters · filed 2026-03-09 | $178.00K derived: sum of 3 quarters · filed 2026-03-09 | $1.89M derived: sum of 4 quarters · filed 2026-03-09 | |||
| 2024-12-31 | $65.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $151.00K derived: sum of 2 quarters · filed 2026-03-09 | $1.87M derived: sum of 3 quarters · filed 2026-03-09 | $2.24M 10-K · filed 2026-03-09 | |||
| 2024-09-30 | $86.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $1.80M derived: sum of 2 quarters · filed 2025-11-12 | $2.17M 10-Q · filed 2025-11-12 | $3.01M derived: sum of 4 quarters · filed 2025-11-12 | |||
| 2024-06-30 | $1.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $2.08M 10-Q · filed 2025-08-12 | $2.92M derived: sum of 3 quarters · filed 2025-08-12 | $6.61M derived: sum of 4 quarters · filed 2025-08-12 | |||
| 2024-03-31 | $370.00K 10-Q · filed 2025-05-12 | $1.21M derived: sum of 2 quarters · filed 2025-05-12 | $4.90M derived: sum of 3 quarters · filed 2025-05-12 | $5.14M derived: sum of 4 quarters · filed 2025-05-12 | |||
| 2023-12-31 | $840.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17 | $4.53M derived: sum of 2 quarters · filed 2025-03-17 | $4.77M derived: sum of 3 quarters · filed 2025-03-17 | $5.65M 10-K · filed 2025-03-17 | |||
| 2023-09-30 | $3.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $3.93M derived: sum of 2 quarters · filed 2024-11-12 | $4.81M 10-Q · filed 2024-11-12 | $481.10K 10-Q · filed 2023-11-13 | $6.72M derived: sum of 4 quarters · filed 2024-11-12 | ||
| 2023-06-30 | $242.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $1.12M 10-Q · filed 2024-08-13 | $3.03M derived: sum of 3 quarters · filed 2024-08-13 | $12.99M derived: sum of 4 quarters · filed 2024-08-13 | |||
| 2023-03-31 | $882.00K 10-Q · filed 2024-04-29 | $2.79M derived: sum of 2 quarters · filed 2024-04-29 | $12.75M derived: sum of 3 quarters · filed 2024-04-29 | -$449.93M derived: sum of 4 quarters · filed 2024-04-29 | |||
| 2022-12-31 | $1.91M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-04 | $11.87M derived: sum of 2 quarters · filed 2024-03-04 | -$450.81M derived: sum of 3 quarters · filed 2024-03-04 | $15.46M 10-K · filed 2024-03-04 | |||
| 2022-09-30 | $9.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$452.72M derived: sum of 2 quarters · filed 2023-11-13 | $13.55M 10-Q · filed 2023-11-13 | $34.82M derived: sum of 4 quarters · filed 2023-11-13 | |||
| 2022-06-30 | -$462.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-28 | $3.59M 10-Q · filed 2023-07-28 | $24.86M derived: sum of 3 quarters · filed 2023-07-28 | $20.20M derived: sum of 4 quarters · filed 2023-07-28 | |||
| 2022-03-31 | $466.27M 10-Q · filed 2023-05-08 | $1.72K 10-Q · filed 2022-05-09 | $487.54M derived: sum of 2 quarters · filed 2023-05-08 | $482.89M derived: sum of 3 quarters · filed 2023-05-08 | $487.54M derived: sum of 4 quarters · filed 2023-05-08 | ||
| 2021-12-31 | $21.27M derived: 10-K 12 month − 10-Q/A 9 month · filed 2023-02-15 | $16.61M derived: sum of 2 quarters · filed 2023-02-15 | $21.27M derived: sum of 3 quarters · filed 2023-02-15 | $21.27M 10-K · filed 2023-02-15 | $21.30M 10-K · filed 2022-03-31 | ||
| 2021-09-30 | -$4.65M derived: 10-Q/A 9 month − 10-Q 6 month · filed 2022-03-31 | $532.00 derived: sum of 2 quarters · filed 2022-08-08 | $4.66K 10-Q/A · filed 2022-03-31 | $804.19K derived: sum of 4 quarters · filed 2022-08-08 | |||
| 2021-06-30 | $4.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $4.66M 10-Q · filed 2022-08-08 | $5.46M derived: sum of 3 quarters · filed 2022-08-08 | ||||
| 2021-03-31 | $4.13K 10-Q · filed 2022-05-09 | $803.65K derived: sum of 2 quarters · filed 2022-05-09 | |||||
| 2020-12-31 | $799.53K derived: 10-K 12 month − 10-Q/A 9 month · filed 2022-03-31 | $800.00K 10-K · filed 2022-03-31 | |||||
| 2020-09-30 | $471.00 10-Q/A · filed 2022-03-31 |